Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53.9M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
26.1M
-
Shares change
-
+26.1M
-
Total reported value, excl. options
-
$457M
-
Value change
-
+$457M
-
Number of buys
-
25
-
Price
-
$17.59
Significant Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q3 2021
25 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.1M shares
of 53.9M outstanding shares and own 48.4% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.24M shares), BOXER CAPITAL, LLC (6.32M shares), FMR LLC (1.91M shares), BVF INC/IL (1.69M shares), JANUS HENDERSON GROUP PLC (1.37M shares), FRAZIER MANAGEMENT LLC (1.25M shares), Cormorant Asset Management, LP (1.07M shares), Logos Global Management LP (1M shares), PERCEPTIVE ADVISORS LLC (988K shares), and WELLINGTON MANAGEMENT GROUP LLP (695K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.